Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Royal Philips Acquires Spectranetics
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to The Spectranetics Corporation in connection with…
Teladoc, Inc. $275 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Teladoc, Inc. of $275 million aggregate…
Bristol-Myers Squibb Company Debt Tender Offer
Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875%…
Loxo Oncology, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500…
Cardinal Health $5.2 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Cardinal Health, Inc…
NanoString Technology Public Stock Offering
Davis Polk advised the sole underwriter in connection with the public offering of 3,450,000 shares of common stock of…
Achaogen Common Stock Offering
Davis Polk advised the joint book-running managers in connection with the $112.5 million public offering of common…
Alnylam Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the sole book-running manager of a $359.35 million SEC-registered offering of 5,000,000 shares of common…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000…
DexCom, Inc. $350 Million Convertible Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by DexCom, Inc. of $350 million…